$IDYA

Ideaya Biosciences Inc

  • NASDAQ
  • Biotechnology
  • Pharmaceuticals: Major
  • Health Technology

PRICE

$11.08 ▲5.423%

Last Close

VOLUME

236,515

DAY RANGE

9.99 - 10.66

52 WEEK

8.14 - 28

Join Discuss about IDYA with like-minded investors

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, September 23, 2021 Futures Up/Down % Last Dow 162.00 0.47% 34,291 S&P 500 23.25 0.53% 4,407 Nasdaq 83.50 0.55% 15,247 U.S. stocks are looking at another move higher following strong gains on Wednesday despite the FOMC taking a more “hawkish” stance on both rates and the timeline on asset purchase tapering during yesterday’s meeting. Stocks jumped on Wednesday after the Federal Reserve cleared the way to ease monthly bond purchases “soon” and signaled interest rate increases may follow more quickly than expected. Stocks pared gains late as Fed Chair Jerome Powell spoke at his press conference but still closed up solidly. Fed officials indicated that they see interest rates seen rising to 1% in 2023, faster than projected by the Fed in its projections in June, and then to 1.8% in 2024. Nine of eleven major S&P 500 sectors ended the day higher. However, of note, all 11 groups retreated from the moments before Powell’s press conference began, into the close. The Dow Transport index slid to 6-month lows following weakness from Fed-Ex (FDX) earnings results and guidance the night prior. In Asian markets, The Nikkei Index was closed, the Shanghai Index rose 13 points to 3,642 and the Hang Seng Index gained 289 points to 24,510. In Europe, the German DAX is up over 130 points (0.89%) to 15,645, while the FTSE 100 rises about 20-points to move above 7,100. Oil prices are slipping but still holds near two-month high with global stockpiles tightening. In China news, the WSJ reported China is preparing for the “demise” of Evergrande, signaling Beijing’s reluctance to get involved and bail out the company. Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 320K 8:30 AM EST Continuing Claims…est. 2.65M 9:45 AM ET Markit Manufacturing PMI, Sept-F…est. 61.5 9:45 AM ET Markit Services PMI, Sept-F…est. 55.0 9:45 AM ET Markit Composite PMI-Sept-F 10:00 AM ET Leading Index MoM for Aug…est. +0.7% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Kansas City Fed Manufacturing for Sept…prior 22 Earnings Calendar: Earnings Before the Open: DRI, DYNT, IWSY, RAD Earnings After the Close: AEHR, AGTC, AIR, CAMP, $COST, MTN, $NKE, PRGS, $RSSS Other Key Events: Credit Suisse 7th Annual Oil & Gas Non-Bus Tour (virtual), 9/21-9/23 DA Davidson Diversified Industrials & Services Conference (virtual), 9/22-9/23 Goldman Sachs 30th Annual Communacopia Conference (virtual), 9/21-9/23 JPMorgan 12th Annual U.S. All Stars Conference (virtual), 9/21-9/23 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual), 9/20-9/23 Roth Capital 8th Annual Solar Symposium (virtual), 9/20-9/23 Sidoti Fall Small Cap Conference (virtual), 9/22-9/23 Wells Fargo 4th Annual Consumer Conference (virtual), 9/22-9/23 Market Closing Prices Yesterday The S&P 500 Index gained 41.45 points, or 0.95%, to 4,395.64 The Dow Jones Industrial Average rose 338.48 points, or 1.00%, to 34,258.32 The Nasdaq Composite jumped 150.45 points, or 1.02%, to 14896.85 The Russell 2000 Index advanced 32.38 points, or 1.48% to 2,218.56 Macro Up/Down Last Nymex -0.32 71.91 Brent -0.27 75.92 Gold 3.80 1,772.00 EUR/USD 0.0028 1.1715 JPY/USD 0.11 109.89 10-Year Note +0.003 1.335% World News China is preparing for the “demise” of Evergrande, signaling Beijing’s reluctance to get involved and bail out the company (the gov’t will only step in should the company’s failure turn disorderly) – WSJ https://on.wsj.com/3i2x8WH Sector News Breakdown Consumer Steelcase ($SCS) 2Q EPS $0.21 vs est. $0.23 on revs $724.8Mm vs est. $761.3Mm; guides 3Q revs $755-785Mm vs est. $713Mm, sees 3Q EPS $0.07-0.11 vs est. $0.09 Funko ($FNKO) entered into a new credit agreement for a term loan facility of $180M and a revolving credit facility of $100M that mature September 17, 2026 Brilliant Earth ($BRLT)33M share IPO priced at $12.00 Hyatt ($H) 7M share Secondary priced at $74.50 Sovos Brands ($SOVO)3M share IPO priced at $12.00 Energy, Industrials & Materials HB Fuller (FUL) 3Q adj EPS $0.79 vs est. $0.79 on revs $827Mm vs est. $797.6Mm; guides FY revs +17-18% vs est. +14.4%, sees FY adj EBITDA abut $460-470Mm vs est. $463Mm KB Homes (KBH) 3Q EPS $1.60 vs est. $1.62 on revs $1.47B vs est. $1.57B; qtrly homes delivered +35% to $3,425, ending backlog value +89% to $4.84B; inventory +19% to $4.66B as of Aug. 31; repurchased 4.7Mm shares for $188.2Mm Northrop Grumman ($NOC) upgraded to Neutral from Sell at Goldman Sachs with a $350 price target and General Dynamics (GD) also upgraded to Neutral from Sell at Goldman Sachs with a $176 price target in the defense sector; L3Harris Technologies (LHX) downgraded to Sell from Neutral at Goldman Sachs with a $207 price target, Lockheed Martin (LMT) downgraded to Neutral from Buy with $402 tgt and Woodward ($WWD) downgraded to Sell from Neutral with $102 tgt Loop Capital started Regal Beloit Corp (RBC) with a Buy rating and $180 price target and Timken (TKR) with a Hold rating and $72 price target Grinrod Shipping ($GRIN)842M share Spot Secondary priced at $13.50 Syncrude Canada, majority-owned by Suncor Energy ($SU), cut September supplies due to a mechanical disruption at its Alberta oil sands site, Bloomberg reported Financials Chinese Estates (Holdings) Ltd. is planning to sell all of its shares in China Evergrande Group, as the property investment company is worried about the recent stock-price volatility and financial condition of debt-laden Evergrande. Chinese Estates, which currently holds 751.09 million shares or a 5.66% stake in Evergrande, expects to record a realized loss on the stake of about 1.38 billion Hong Kong dollars ($177.2 million) for the year ending December Remitly Global (RELY)16M share IPO priced at $43.00 The9 ($NCTY), Polygon, an Ethereum scaling platform, and Protocol Labs, a major contributor of open-source projects are forming an ecosystem collaboration on NCTY’s Non-Fungible Token (NFT) platform NFTSTAR and GameFi Play-to-Earn projects Safehold (S$AFE)2M share Secondary priced at $76.00 Willis Towers Watson ($WLTW) raises share buyback program by $4B Raymond James Financials ($RJF) posts Private Client Group assets in fee-based accounts of $643.5B grew 33% Y/Y, thanks to the net addition of financial advisers; record client assets under administration of $1.21T rose from $945.2B in the year ago period and $1.18T in the prior month. Healthcare The FDA has granted Emergency Use Authorization for a booster dose of Pfizer ($PFE)/BioNTech’s ($BNTX) COVID-19 vaccine for those 65 and older, those who work in healthcare settings, and adults at high risk of severe COVID-19. The authorization includes people whose “frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19.” Sterling Check (STER)285M share IPO priced at $23.00 Eargo, Inc. (EAR) shares fell -50% on reports it is the target of a criminal investigation by U.S. DOJ related to insurance reimbursement claims submitted on behalf of customers covered by federal employee health plans; the co is withdrawing its financial guidance for fiscal year ending December 31, 2021 Spectrum Pharma (SPPI) Journal of Clinical Oncology Abstract listing for co.’s ‘poziotinib for patients with HER2 exon 20 mutant non–small-cell lung cancer Cigna Corp (CI) named Eric Palmer as president and chief executive officer of Evernorth, its health services unit that mainly houses its pharmacy benefit management business; also announced several other leadership changes Medirom Healthcare (MRM) rises 39%; after saying that it will buy Japanese private hair salon operator Zacc Kabushiki Kaisha in an all-cash deal of 370.0 mln yen ($3.36M) Thorne HealthTech (THRN) 7M share IPO priced at $10.00 Stifel initiated Buy ratings on Mirati Therapeutics (MRTX) with a $202 price target, Kinnate Biopharma (KNTE) with a $32 price target, and Repare Therapeutics (RPTX) with a $48 price target; Hold ratings on Ideaya Biosciences (IDYA) and Revolution Medicines (RVMD) Needham started SAGE Therapeutics (SAGE) at a Buy and added it to its Conviction List; also initiated Buy ratings on Intra-Cellular Therapeutics (ITCI), Avadel Pharmaceuticals (AVDL), Jazz Pharmaceuticals ($JAZZ), Biogen ($BIIB), Harmony Biosciences ($HRMY), and Hold ratings on Neurocrine Biosciences ($NBIX) and ACADIA Pharmaceuticals (ACAD) Technology, Media & Telecom Blackberry ($BB) shares rose 8% after earnings; Q2 EPS ($0.06) vs est. ($0.07) on revenue $175M vs est. $163.5M Facebook ($FB) chief technology officer Mike Schroepfer said in a Facebook post: “After 13 amazing years at Facebook, I have made the decision to step down as Chief Technology Officer and transition to a new part time role as Facebook’s first Senior Fellow at the company sometime in 2022 EngageSmart ($ESMT)55M share IPO priced at $26.00 Roku ($ROKU) upgraded to Buy from Neutral at Guggenheim

64 Replies 11 👍 10 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, July 8, 2021 Futures Up/Down % Last Dow -494.00 1.43% 34,074 S&P 500 -60.25 1.40% 4,289 Nasdaq -196.50 1.33% 14,606 Stocks slide around the globe, as the S&P 500 and Nasdaq Composite tumble following fresh all-time highs on Wednesday. A delayed reaction? Stocks were little changed late afternoon following the release of the FOMC Minutes from its prior meeting, where Fed officials saw a tightening of monetary policy potentially happening sooner than expected as the economy recovers from the pandemic, but no move to taper asset purchases seems imminent. At the same time, worries about the economic recovery continue to weigh as the Covid-19 delta variant has spread rapidly in countries with lagging vaccination rates, as the WHO urged caution on worldwide reopenings. In Asian markets, The Nikkei Index dropped -248 points to 28,118, the Shanghai Index slid -28 points to 3,525 and the Hang Seng Index tumbled 2.9% or 800 points to settle at 27,153. In Europe, markets are broadly lower as the German DAX drops over 270 points to 15,420, while the FTSE 100 slides around 2% to hold just above the 7,000 level. European equities are deep in the red with most indexes printing fresh lows for the week. Eurostoxx 50 drops as much as 1.9%, while all Stoxx 600 sectors are in the red, with miners, retail and banks performing the worst. Market Closing Prices Yesterday The S&P 500 Index gained 14.59 points, or 0.34%, to 4,358.13 The Dow Jones Industrial Average rose 104.42 points, or 0.30%, to 34,681.79 The Nasdaq Composite edged higher 1.42 points, or 0.01%, to 14,665.06 The Russell 2000 Index declined -21.66 points, or 0.95% to 2,252.85 Events Calendar for Today 8:30 AM ET Weekly Jobless Claims…est. 350K 8:30 AM EST Continuing Claims…est. 3.335M 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM ET Weekly DOE Inventory Data 3:00 PM ET Consumer Credit for May…est. $18.4B Earnings Calendar: Earnings Before the Open: $HELE Earnings After the Close: $ACCD, $DCT, $KSHB, $LEVI, $PSMT Other Key Events: China Producer Price Index and Consumer Price Index for June Macro Up/Down Last Nymex -0.80 71.40 Brent -0.66 72.77 Gold 7.10 1,810.75 EUR/USD 0.0036 1.1826 JPY/USD -0.82 109.84 10-Year Note -0.066 1.255% Sector News Breakdown Consumer GAN ($GAN) rises after saying sees Q2 revs between $34-$35M, beating the consensus of $23.98M; positive Adj. EBITDA to be $3-$7M as higher than expected revenue more than offset strategic investments in talent and technology Overstock ($OSTK) initiated with a Buy and $150 tgt at Needham WD-40 ($WDFC) Q3 EPS $1.52 vs. est. $1.15; Q3 sales rose 39% to $136.4M vs. est. $108.33M; sees FY sales $475m-$490m vs. rest. $461.85M; do not expect to see sales growth of current magnitude over long-term Tesla ($TSLA) introduced a new, lower-priced version of the Model Y to the China market; the Standard Range Model Y starts at 276,000 yuan ($42,600) after government subsidies and incentives; Tesla began taking orders for the vehicle on Thursday. Didi ($DIDI) shares on track for a 4th straight decline after IPO last week, extending the losses suffered as Asian stocks listed in New York also drop following a day of declines for tech companies in Hong Kong. Stellantis ($STLA) slips after saying adjusted operating income margins in 1H are expected to exceed previously communicated FY margin guidance range of 5.5% to 7.5%; said expects negative industrial free cash flows in 1H Energy, Industrials and Materials American Petroleum Institute ($API) showed a draw of 7.98M barrels of oil for the latest week; gasoline inventories showed a draw of 2.74M barrels, distillate inventories show a build of 1.09M barrels and Cushing inventories show a build of 152K barrels. Freeport McMoRan ($FCX) downgraded to Underweight from Equal Weight at Barclays Rio Tinto ($RIO) and South Korean steelmaker POSCO agreed to jointly develop technologies to transition to a low-carbon emission steel value chain. Maxar Technologies ($MAXR) contracts for WorldView Legion satellite constellation capacity through an expanded agreement with a key international defense and intelligence customer (multi-year, $35M contract) Sonoco ($SON) updates $115 million project horizon progress; announces intentions to close 70,000 tons/year of capacity at Hartsville mill complex; investment to convert Hartsville, S.C., corrugated medium machine to urb scheduled to be completed in q2 of 2022 The Federal Aviation Administration issued an emergency directive requiring main rotor inspections for ~400 Textron ($TXT) Bell helicopters after Canadian and U.S. investigators discovered a possible flaw while probing a fatal crash last week. Financials Cryptocurrency-exposed stocks like $RIOT, $MARA, $MSTR, looking sharply lower in premarket trading with Bitcoin sinking back below $33,000 per token, down over 5%, with Ethereum down over 7% to slip below $2,200 Charles Schwab ($SCHW) downgraded to Neutral from Conviction Buy at Goldman Sachs Pzena Investment Management Inc. ($PZN) preliminary total AUM as of June 30, 2021 was $53.1 bln Healthcare Amgen ($AMGN) said the U.S. FDA has accepted a Biologics License Application ($BLA) and granted Priority Review for Tezepelumab in the treatment of asthma; Tezepelumab is being developed by Amgen in collaboration with AstraZeneca ($AZN) Ideaya Biosciences ($IDYA)64M share Secondary priced at $17.25 SeaSpine Holdings ($SPNE) said the U.S. FDA has granted a 510k clearance for the company’s 7D Percutaneous Spine Module for minimally invasive surgery Technology, Media & Telecom Alphabet Inc’s ($GOOGL) slides as thirty-seven U.S. states and district attorneys general sued Google on Wednesday, alleging the search giant bought off competitors; also alleged that the co was using restrictive contracts to unlawfully maintain a monopoly for its app store on Android phones Tessco Technologies ($TESS) shares jump over 30% after the company said Wednesday evening it expects 2022 1Q total revenue of $105M, 9% higher than a year earlier

127 Replies 14 👍 12 🔥

profile
@dros #droscrew
recently

+Initiations 10/7: $CNTG $DT $HEI $IDYA $IIVI $KDNY $NEWR $NFIN $NOVA $PEN $SPWR $SWI -Initiations 10/7: $GSKY

131 Replies 9 👍 15 🔥

Key Metrics

Market Cap

406.11 M

Beta

1.22

Avg. Volume

325.03 K

Shares Outstanding

38.64 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-09

Next Dividend Date

Company Information

IDEAYA Biosciences Inc. is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies. IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality - which represents an emerging class of precision medicine targets.

CEO: Yujiro Hata

Website:

HQ: 7000 Shoreline Ct Ste 350 South San Francisco, 94080-7604 California

Related News